ArticleDiagnostics (Basel, Switzerland)2022
Generalization Challenges in Drug-Resistant Tuberculosis Detection from Chest X-rays.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- PulmoX-Net: a channel-attention enhanced deep learning model for multi-class pulmonary pathology classification in chest radiography.Frontiers in medicine · 2026Article
- Accuracy of Machine Learning in Identifying Drug Resistance in Tuberculosis: A Systematic Review and Meta-Analysis.Health science reports · 2025Review
- Addressing Class Imbalance with Latent Diffusion-based Data Augmentation for Improving Disease Classification in Pediatric Chest X-rays.Proceedings. IEEE International Conference on Bioinformatics and Biomedicine · 2024Article
- Automated Pulmonary Tuberculosis Severity Assessment on Chest X-rays.Journal of imaging informatics in medicine · 2024Article
- Semantically redundant training data removal and deep model classification performance: A study with chest X-rays.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2024Article
- Tuberculosis Chest X-Ray Image Retrieval System Using Deep Learning Based Biomarker Predictions.Proceedings of SPIE--the International Society for Optical Engineering · 2024Article
- Article
- Combining Radiological and Genomic TB Portals Data for Drug Resistance Analysis.IEEE access : practical innovations, open solutions · 2023Article
- Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China.Infection and drug resistance · 2023Article
- Computer-aided diagnosis using embedded ensemble deep learning for multiclass drug-resistant tuberculosis classification.Frontiers in medicine · 2023Article
- Drug-Resistant Tuberculosis Treatment Recommendation, and Multi-Class Tuberculosis Detection and Classification Using Ensemble Deep Learning-Based System.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Embedded AMIS-Deep Learning with Dialog-Based Object Query System for Multi-Class Tuberculosis Drug Response Classification.Diagnostics (Basel, Switzerland) · 2022Article
- Editorial on Special Issue "Artificial Intelligence in Image-Based Screening, Diagnostics, and Clinical Care of Cardiopulmonary Diseases".Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Classification of drug-resistant tuberculosis (DR-TB) and drug-sensitive tuberculosis (DS-TB) from chest radiographs remains an open problem. Our previous cross validation performance on publicly available chest X-ray (CXR) data combined with image augmentation, the addition of synthetically generated and publicly available images achieved a performance of 85% AUC with a deep convolutional neural network (CNN). However, when we evaluated the CNN model trained to classify DR-TB and DS-TB on unseen data, significant performance degradation was observed (65% AUC). Hence, in this paper, we investigate the generalizability of our models on images from a held out country's dataset. We explore the extent of the problem and the possible reasons behind the lack of good generalization. A comparison of radiologist-annotated lesion locations in the lung and the trained model's localization of areas of interest, using GradCAM, did not show much overlap. Using the same network architecture, a multi-country classifier was able to identify the country of origin of the X-ray with high accuracy (86%), suggesting that image acquisition differences and the distribution of non-pathological and non-anatomical aspects of the images are affecting the generalization and localization of the drug resistance classification model as well. When CXR images were severely corrupted, the performance on the validation set was still better than 60% AUC. The model overfitted to the data from countries in the cross validation set but did not generalize to the held out country. Finally, we applied a multi-task based approach that uses prior TB lesions location information to guide the classifier network to focus its attention on improving the generalization performance on the held out set from another country to 68% AUC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.